Skip to main content
SpringerLink
Log in

CQ51. Are Measurements of Calcitonin and CEA Useful as Markers of Recurrence After Surgery for Medullary Carcinoma?

  • Chapter
  • First Online:
Treatment of Thyroid Tumor

  • 1327 Accesses

Abstract

Medullary thyroid carcinoma originates from parafollicular c-cells, which secrete calcitonin. Since medullary carcinoma cells also secrete calcitonin, this CQ examined whether calcitonin is a marker of recurrence. The same study was performed for CEA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Barbet J, Campion L, Kraeber-Bodere F et al (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90:6077–6084 (RS)

    Article  PubMed  CAS  Google Scholar 

  2. Machens A, Ukkat J, Hauptmann S et al (2007) Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg 142:289–293 (RS)

    Article  PubMed  CAS  Google Scholar 

  3. de Groot JW, Kema IP, Breukelman H et al (2006) Biochemical markers in the follow-up of medullary thyroid cancer. Thyroid 16:1163–1170 (PS)

    Article  PubMed  Google Scholar 

  4. Elisei R, Bottici V, Luchetti F et al (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163–168 (RS)

    Article  PubMed  CAS  Google Scholar 

  5. Elisei R (2008) Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:941–951 (NR)

    Article  PubMed  CAS  Google Scholar 

  6. Takami H (2007) (Text in Japanese) Konsensasu Ganchiryo 6:120–122 (NR)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgery, Tokyo Medical University, Ibaraki Medical Center, 3-20-1 Chuo, Amimachi, Inashikigun, Ibaraki, 300-0395, Japan

    Minoru Fujimori

  2. Department of Breast and Endocrine Surgery, Clinical Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

    Hisato Hara

  3. Department of Thoracic and Thyroid Surgery, Tokyo Medical University, Tokyo, Japan

    Hidemitsu Tsutsui

Authors
  1. Minoru Fujimori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisato Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hidemitsu Tsutsui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minoru Fujimori .

Editor information

Editors and Affiliations

  1. Ito Hospital, 4-3-6 Jinguumae, Shibuya-ku, Tokyo, 150-8308, Japan

    Hiroshi Takami

  2. , Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe, 650-0011, Japan

    Yasuhiro Ito

  3. Noguchi Thyroid Clinic and Hospital Foun, 6-33 Noguchinaka-machi, Beppu, 874-0932, Japan

    Hitoshi Noguchi

  4. , Department of Breast and Endocrine Surge, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan

    Akira Yoshida

  5. , Department of Endocrine Surgery, Tokyo Women's Medical University, 8-1 Kawada- cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Takahiro Okamoto

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Japan

About this chapter

Cite this chapter

Fujimori, M., Hara, H., Tsutsui, H. (2013). CQ51. Are Measurements of Calcitonin and CEA Useful as Markers of Recurrence After Surgery for Medullary Carcinoma?. In: Takami, H., Ito, Y., Noguchi, H., Yoshida, A., Okamoto, T. (eds) Treatment of Thyroid Tumor. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54049-6_72

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54049-6_72

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54048-9

  • Online ISBN: 978-4-431-54049-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation